| Serial Number | 97386851 |
| Word Mark | TEZZURA |
| Filing Date | Thursday, April 28, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Monday, August 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 4, 2023 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 3, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Monday, May 2, 2022 | NEW APPLICATION ENTERED |
| Tuesday, May 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 15, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, February 15, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 15, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 22, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 22, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 22, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 30, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 22, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, May 9, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, May 9, 2023 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, June 14, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 4, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 4, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 29, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 27, 2024 | SOU EXTENSION 1 FILED |
| Monday, August 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 19, 2024 | SOU EXTENSION 2 FILED |
| Monday, August 19, 2024 | SOU EXTENSION 2 GRANTED |
| Monday, August 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 27, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |